Canine Heartworm Disease: Treatment and Welfare Considerations
Heartworm Disease in Dogs
Heartworm disease (Dirofilaria immitis) is a serious, potentially fatal parasitic infection transmitted by mosquitoes, affecting dogs across tropical, subtropical, and temperate regions worldwide. Adult worms living in the pulmonary arteries and right heart cause progressive cardiopulmonary disease. Treatment is complex, carries significant risks, and requires months of strict exercise restriction — making prevention the overwhelming welfare preference.
Transmission and Life Cycle
Mosquitoes ingest microfilariae (first-stage larvae) from an infected dog's blood during feeding. Over 10-14 days in the mosquito (temperature dependent), larvae develop to infective third-stage larvae. When the infected mosquito feeds again, larvae are deposited on the dog's skin and penetrate through the bite wound. Over 6-7 months, larvae migrate through tissues to reach the pulmonary arteries, where they develop into adult worms. Adults can live 5-7 years, continuously producing microfilariae.
Pathophysiology and Clinical Signs
Adult heartworms (15-30cm long) in the pulmonary arteries and right heart cause endothelial damage, pulmonary arteritis, and right-sided heart failure as worm burden increases. Clinical signs reflect cardiopulmonary disease severity:
- Class 1 (mild): Minimal or no clinical signs; occasional soft cough
- Class 2 (moderate): Exercise intolerance, persistent cough, abnormal lung sounds
- Class 3 (severe): Exercise intolerance at rest, respiratory distress, heart failure signs, weight loss, syncope
- Caval syndrome: Large worm burdens in right heart cause acute cardiovascular collapse — a life-threatening emergency requiring surgical worm extraction
Treatment Protocol
Adult heartworm treatment uses melarsomine dihydrochloride (Immiticide/Diroban) — an arsenic-based drug injected into lumbar muscles. The three-dose ('split-dose') protocol provides safer worm kill than the two-dose protocol by reducing simultaneous worm death and thromboembolic complications:
- Day 1: Single melarsomine injection
- Days 30 and 31: Two further injections 24 hours apart
- Strict exercise restriction for 6-8 weeks following each injection phase
Doxycycline (4 weeks pre-treatment) targets Wolbachia endosymbionts in heartworms, reducing worm viability and inflammatory responses. Microfilaricide treatment follows adult worm kill.
Exercise Restriction — A Critical and Difficult Welfare Consideration
The most challenging aspect of treatment is strict exercise restriction for 8+ weeks after treatment. As dying worms are resorbed, physical exertion increases blood flow through diseased pulmonary arteries, dramatically increasing risk of fatal pulmonary thromboembolism. Dogs must be restricted to leash walking only; no running, jumping, or excitement. This creates welfare challenges from confinement and frustration, particularly in young, active dogs. Mental enrichment (puzzle feeders, calm training) helps manage restriction stress.
Prevention — The Clear Welfare Priority
Monthly macrocyclic lactone preventatives (ivermectin, milbemycin, selamectin) are highly effective, inexpensive, and safe. Where heartworm is endemic, year-round prevention eliminates disease risk entirely. Annual testing ensures early detection if prevention lapses occur. Prevention is vastly preferable to the welfare burden of treatment.
This page is part of the Animal Welfare Hub — providing evidence-based information to improve the lives of animals. Return to home.